Skip to main content

Protection by Glutamine After Ischemia/Reperfusion Injury

  • Chapter
  • First Online:
Glutamine in Clinical Nutrition

Part of the book series: Nutrition and Health ((NH))

  • 1652 Accesses

Abstract

Ischemia/reperfusion (I/R) occurs in a wide range of clinical scenarios including trauma, shock, transplantation, stroke, myocardial infarction, coronary angioplasty, thrombolytic therapy, coronary revascularization, and autoimmune diseases. Ischemia can cause tissue and organ damage due to an insufficient oxygen and glucose, which are necessary for cellular metabolism, which subsequently results in tissue or organ dysfunction. Although reperfusion is necessary to attenuate injury of ischemic tissues, it can trigger a cascade of events leading to additional tissue injury and even remote organ injury. Therefore, I/R injury contributes to the pathophysiology of a wide range of clinical diseases and is associated with considerable morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Estívariz CF, Griffith DP, Luo M, et al. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. J Parenter Enteral Nutr. 2008;32:389–402.

    Article  Google Scholar 

  2. Kim M, Wischmeyer PE. Glutamine. World Rev Nutr Diet. 2013;105:90–6.

    Article  PubMed  Google Scholar 

  3. Demirkan A, Savaş B, Melli M. Endotoxin level in ischemia-reperfusion injury in rats: effect of glutamine pretreatment on endotoxin levels and gut morphology. Nutrition. 2010;26:106–1011.

    Article  CAS  PubMed  Google Scholar 

  4. Demirkan A, Orazakunov E, Savaş B, et al. Enteral glutamine pretreatment does not decrease plasma endotoxin level induced by ischemia-reperfusion injury in rats. World J Gastroenterol. 2008;14:463–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Medeiros AC, Chacon DA, Sales VS, et al. Glucan and glutamine reduce bacterial translocation in rats subjected to intestinal ischemia-reperfusion. J Invest Surg. 2006;19:39–46.

    Article  PubMed  Google Scholar 

  6. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun. 1979;23:403–4011.

    CAS  PubMed Central  PubMed  Google Scholar 

  7. Kozar RA, Schultz SG, Hassoun HT, et al. The type of sodium-coupled solute modulates small bowel mucosal injury, transport function, and ATP after ischemia/reperfusion injury in rats. Gastroenterology. 2002;123:810–6.

    Article  CAS  PubMed  Google Scholar 

  8. Peng Z, Ban K, Sen A, et al. Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut. Shock. 2012;38:57–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Kozar RA, Schultz SG, Bick RJ, et al. Enteral glutamine but not alanine maintains small bowel barrier function after ischemia/reperfusion injury in rats. Shock. 2004;21:433–7.

    Article  CAS  PubMed  Google Scholar 

  10. Sato N, Moore FA, Kone BC, et al. Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G616–23.

    Article  CAS  PubMed  Google Scholar 

  11. Sato N, Moore FA, Smith MA, et al. Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion. J Trauma. 2005;58:455–4561.

    Article  CAS  PubMed  Google Scholar 

  12. Wu GH, Wang H, Zhang YW, et al. Glutamine supplemented parenteral nutrition prevents intestinal ischemia-reperfusion injury in rats. World J Gastroenterol. 2004;10:2592–4.

    CAS  PubMed  Google Scholar 

  13. Harward TR, Coe D, Souba WW, et al. Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res. 1994;56:351–5.

    Article  CAS  PubMed  Google Scholar 

  14. Ikeda S, Zarzaur BL, Johnson CD, et al. Total parenteral nutrition supplementation with glutamine improves survival after gut ischemia/reperfusion. J Parenter Enteral Nutr. 2002;26:169–73.

    Article  CAS  Google Scholar 

  15. Omata J, Fukatsu K, Ueno C, et al. Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. J Surg Res. 2007;143:260–4.

    Article  CAS  PubMed  Google Scholar 

  16. Fukatsu K, Ueno C, Hashiguchi Y, et al. Glutamine infusion during ischemia is detrimental in a murine gut ischemia/reperfusion model. J Parenter Enteral Nutr. 2003;27:187–92.

    Article  CAS  Google Scholar 

  17. Mendes-Braz M, Elias-Miró M, Jiménez-Castro MB, et al. The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotechnol. 2012;2012:298657.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147:153–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Clavien PA, Selzner M, Rüdiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238:843–50.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Araújo Júnior RJ, Silva Júnior RG, et al. Preconditioning with l-alanyl-glutamine reduces hepatic ischemia-reperfusion injury in rats. Acta Cir Bras. 2011;26 Suppl 1:8–13.

    Article  PubMed  Google Scholar 

  21. Zhang SC, Shi Q, Feng YN, et al. Tissue-protective effect of glutamine on hepatic ischemia-reperfusion injury via induction of heme oxygenase-1. Pharmacology. 2013;91:59–68.

    Article  CAS  PubMed  Google Scholar 

  22. Schuster H, Blanc MC, Bonnefont-Rousselot D, et al. Protective effects of glutamine dipeptide and alpha-tocopherol against ischemia-reperfusion injury in the isolated rat liver. Clin Nutr. 2009;28:331–7.

    Article  CAS  PubMed  Google Scholar 

  23. Noh J, Behrends M, Choi S, et al. Glutamine does not protect against hepatic warm ischemia/reperfusion injury in rats. J Gastrointest Surg. 2006;10:234–9.

    Article  PubMed  Google Scholar 

  24. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–146.

    Article  PubMed  Google Scholar 

  25. Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92–100.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Wischmeyer PE, Jayakar D, Williams U, et al. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. J Parenter Enteral Nutr. 2003;27:396–403.

    Article  CAS  Google Scholar 

  27. Liu J, Marchase RB, Chatham JC. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol. 2007;42:177–85.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Wischmeyer PE, Vanden Hoek TL, Li C, et al. Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia-reperfusion injury. J Parenter Enteral Nutr. 2003;27:116–22.

    Article  CAS  Google Scholar 

  29. Pires VL, Souza JR, Guimarães SB, et al. Preconditioning with l-alanyl-l-glutamine in a Mongolian gerbil model of acute cerebral ischemia/reperfusion injury. Acta Cir Bras. 2011;26 Suppl 1:14–20.

    Article  PubMed  Google Scholar 

  30. Larson SD, Li J, Chung DH, et al. Molecular mechanisms contributing to glutamine-mediated intestinal cell survival. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1262–71.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Ban K, Kozar RA. Glutamine protects against apoptosis via downregulation of Sp3 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1344–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Santora R, Kozar RA. Molecular mechanisms of pharmaconutrients. J Surg Res. 2010;161:288–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 2004;5:104–12.

    Article  CAS  PubMed  Google Scholar 

  34. Mbodji K, Torre S, Haas V, et al. Alanyl-glutamine restores maternal deprivation-induced TLR4 levels in a rat neonatal model. Clin Nutr. 2011;30:672–7.

    Article  CAS  PubMed  Google Scholar 

  35. Wischmeyer PE, Kahana M, Wolfson R, et al. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol. 2001;90:2403–10.

    CAS  PubMed  Google Scholar 

  36. Zhao Y, Patzer A, Gohlke P, et al. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur J Neurosci. 2005;22:278–82.

    Article  PubMed  Google Scholar 

  37. Sundararajan S, Gamboa JL, Victor NA, et al. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience. 2005;130:685–96.

    Article  CAS  PubMed  Google Scholar 

  38. Ban K, Sprunt JM, Martin S, et al. Glutamine activates peroxisome proliferator-activated receptor-γ in intestinal epithelial cells via 15-S-HETE and 13-OXO-ODE: a novel mechanism. Am J Physiol Gastrointest Liver Physiol. 2011;301:G547–54.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Fiatte C, Huin C, Collet P, et al. Expression of PPARgamma is reduced by medium supplementation with l-glutamine in human colorectal Caco-2 cells. Int J Mol Med. 2008;22:825–32.

    CAS  PubMed  Google Scholar 

  40. Hassoun HT, Zou L, Moore FA, et al. Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2002;282:G1059–68.

    CAS  PubMed  Google Scholar 

  41. Hassoun HT, Kozar RA, Kone BC, et al. Aischemic hypothermia differentially modulates oxidative stress proteins during mesenteric ischemia/reperfusion. Surgery. 2002;132:369–76.

    Article  PubMed  Google Scholar 

  42. Yeh KY, Yeh M, Glass J, et al. Rapid activation of NF-kappaB and AP-1 and target gene expression in postischemic rat intestine. Gastroenterology. 2000;118:525–34.

    Article  CAS  PubMed  Google Scholar 

  43. Zou L, Attuwaybi B, Kone BC. Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2003;284:G713–21.

    CAS  PubMed  Google Scholar 

  44. Esposito E, Mondello S, Di Paola R, et al. Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol. 2011;383:493–508.

    Article  CAS  PubMed  Google Scholar 

  45. Rao J, Qian X, Wang P, et al. All-trans retinoic acid preconditioning protects against liver ischemia/reperfusion injury by inhibiting the nuclear factor kappa B signaling pathway. J Surg Res. 2013;180:e99–106.

    Article  CAS  PubMed  Google Scholar 

  46. Chatterjee PK, Patel NS, Kvale EO, et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 2002;61:862–71.

    Article  CAS  PubMed  Google Scholar 

  47. Otterbein LE, Soares MP, Yamashita K, et al. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24:449–55.

    Article  CAS  PubMed  Google Scholar 

  48. Zhu X, Fan WG, Li DP, et al. Heme oxygenase-1 system and gastrointestinal inflammation: a short review. World J Gastroenterol. 2011;17:4283–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Tsuchihashi S, Zhai Y, Bo Q, et al. Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling. Transplantation. 2007;83:1628–34.

    Article  CAS  PubMed  Google Scholar 

  50. Teng YH, Aquino RS, Park PW. Molecular functions of syndecan-1 in disease. Matrix Biol. 2012;31:3–16.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Ricote M, Glass CK. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta. 2007;1771:926–35.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Welch JS, Ricote M, Akiyama TE, et al. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci U S A. 2003;100:6712–9717.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391:79–82.

    Article  CAS  PubMed  Google Scholar 

  54. Pautz A, Art J, Hahn S, et al. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010;23:75–93.

    Article  CAS  PubMed  Google Scholar 

  55. Cho MK, Suh SH, Kim SG. JunB/AP-1 and NF-kappa B-mediated induction of nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages. Nitric Oxide. 2002;6:319–32.

    Article  CAS  PubMed  Google Scholar 

  56. Wang WP, Guo X, Koo MW, et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol. 2001;281:G586–94.

    CAS  PubMed  Google Scholar 

  57. Ban K, Kozar RA. Enteral glutamine: a novel mediator of PPARgamma in the postischemic gut. J Leukoc Biol. 2008;84:595–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kechen Ban Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ban, K., Kozar, R.A. (2015). Protection by Glutamine After Ischemia/Reperfusion Injury. In: Rajendram, R., Preedy, V., Patel, V. (eds) Glutamine in Clinical Nutrition. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1932-1_35

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1932-1_35

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1931-4

  • Online ISBN: 978-1-4939-1932-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics